GlassScriptPhysician profile
Michael B Dooley
NPI 1982671574
$2,649.12
in general payments reported to CMS, 2019-2025
12 companies · $942 in 2025
The $942 reported for 2025 was more than what 89% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $73.02 · 2022: $561 · 2023: $625 · 2024: $448 · 2025: $942.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,015.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,015.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,761.35 | 2021-2025 | Corevalve Evolut R |
| Atricure, INC. | $279.20 | 2022-2025 | Synergy Ablation System |
| Astrazeneca Pharmaceuticals LP | $153.45 | 2022-2025 | Farxiga, Brilinta |
| Getinge USA Sales, LLC | $127.44 | 2024-2025 | Vasoview Hemopro 2, Cardiohelp |
| Abiomed | $123.91 | 2023 | Impella |
| Abbott Laboratories | $49.22 | 2022-2024 | Navitor |
| Shockwave Medical, INC | $32.84 | 2025 | |
| Corcym INC | $31.03 | 2022 | |
| Teleflex LLC | $30.09 | 2023 | Manta |
| Edwards Lifesciences Corporation | $24.00 | 2022 | |
| Pfizer INC. | $20.10 | 2021 | |
| Livanova USA, INC. | $16.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Dooley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.